With the inspiration, motivation and support from UDCT alumni as well as Prof. G.D.Yadav he has started Cleanchem Laboratories in 2015 immediate after completion of his Ph.D from ICT under guidance of Prof. G.D. Yadav. Under his Leadership a small Startup company Cleanchem is growing very aggressively.Cleanchem is one of the fastest growing Contract Research Organization in India. Under his dynamic leadership Cleanchem has achieved remarkable growth and became one of the most reliable brands in reference standardsmanufacturing in domestic as well as international market.
Dr. Bapu is having more than 16 years of research experience from Industries, Academia in National and International level. He is more focused in Business Strategy, Marketing and Business Development as well as R & D activities. He is a role model for Industry Academia collaborations and signed number of MOU’s with different institutions. He is expertise in R&D, Novel Technology Development, Contract Research and CustomSynthesis, Process Development, Technology transfer to effective commercial Scale operations.He is well versed with Design and development of Novel Catalyst and Catalytic processes,Continuous processes, Catalytic Fixed bed reactors, High pressure reactions, Cryogenic reactions, Green Chemistry and Engineering, Advance Separation and Purification, Nano technology, Material science and Advanced Analytical Techniques, Drug Discovery, Medicinal Chemistry, etc.
Mr. Nitin S. Bondre a pharmaceutical professional with a technical background, Has worked with organisation such as RPG Life Sciences Pvt Ltd, Aastrid Life Sciences Pvt Ltd & Wanbury Ltd for the past 14 years. He is specialised in the areas of Design, synthesis, purification and characterisation of API compounds. Synthesis of drug molecules, Process Development, Process Optimization and Scale up of the process up to production plant, quality, R&D, Compliance & regulatory affairs.
He has filed the number of patent & research paper in his research work, A process for the preparation of avanafil and its novel intermediates (W02015177807A1)
Filed patent of preparation Apremilast impurities(Application ID 201621013195)
Synthesis, Characterization, Identification and Quantification of Sertraline Hydrochloride Related Impurities (European journal of pharmaceutical and medical research October 14, 2016)
Stability-indicating related substances method of Apremilast by HPLC and synthesis and characterization of related impurities using Mass and NMR spectroscopy (International Journal of Current Medical and Pharmaceutical Research February 28, 2017)
Synthesis of 2, 6-dihydroxy-3-phenyldiazenylpyridine and 6-amino-2-hydroxy-3-phenyldiazenylpyridine: an impurity in the process for phenazopyridine hydrochloride a genitor-urinary antiseptic drug (European Journal of Biomedical and Pharmaceutical Sciences November 26, 2016)